Evidence map›Paper›PMID 34267655›Full record

ArticleFrontiers in pharmacology2021

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis.

Ahmed A Abulfathi, Veronique de Jager, Elana van Brakel, Helmuth Reuter, Nikhil Gupte, Naadira Vanker, Grace L Barnes, Eric Nuermberger, Susan E Dorman, Andreas H Diacon and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Ahmed A AbulfathiDivision of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa.
Veronique de JagerTask Applied Science, Bellville, South Africa.
Elana van BrakelTask Applied Science, Bellville, South Africa.
Helmuth ReuterDivision of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa.
Nikhil GupteDepartment of Medicine, Center for Tuberculosis Research, Johns Hopkins University, Baltimore, MD, United States.
Naadira VankerTask Applied Science, Bellville, South Africa.
Grace L BarnesDepartment of Medicine, Center for Tuberculosis Research, Johns Hopkins University, Baltimore, MD, United States.
Eric NuermbergerDepartment of Medicine, Center for Tuberculosis Research, Johns Hopkins University, Baltimore, MD, United States.
Susan E DormanDepartment of Medicine, Medical University of South Carolina, Charleston, SC, United States.
Andreas H DiaconTask Applied Science, Bellville, South Africa.
Kelly E DooleyDivisions of Clinical Pharmacology and Infectious Diseases, Department of Medicine, Johns Hopkins University Center for Tuberculosis Research, Baltimore, MD, United States.
Elin M SvenssonDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Johns Hopkins University · USStellenbosch University · ZATask Applied Science · ZAMedical University of South Carolina · USUppsala University · SE

Funding

Mentoring Investigators in HIV and Tuberculosis Therapeutics ResearchK24AI150349 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DOOLEY, KELLY E. · 2020 to 2025
$789k
FDA HHS R01 FD005724NIAID NIH HHS K24 AI150349
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug sensitive TBmeropenempharmacokinetics analysispopulation pharmacokinetic (PK) modeltuberculosis

Identifiers

PMID34267655
PMCPMC8275874
OpenAlexW3176608587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.